ArticleBlood cancer discovery2021

Epigenetic Rewiring of BCR Signaling as a Novel Mechanism of Ibrutinib Resistance in ABC-DLBCL.

Laura PasqualucciPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.